(Q38113210)

English

Immunology and bone

scientific article published on 07 June 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 August 2017

Immunology and bone (English)

1 reference

Europe PubMed Central

29 August 2017

0 references

author name string

Lynett Danks

1

1 reference

Europe PubMed Central

29 August 2017

Hiroshi Takayanagi

2

1 reference

Europe PubMed Central

29 August 2017

publication date

7 June 2013

1 reference

Europe PubMed Central

29 August 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

Journal of Biochemistry

1 reference

Europe PubMed Central

29 August 2017

154

1 reference

Europe PubMed Central

29 August 2017

1

1 reference

Europe PubMed Central

29 August 2017

29-39

1 reference

Europe PubMed Central

29 August 2017

New insights into osteoclastogenic signaling mechanisms

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Bone loss in inflammatory disorders

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Osteoimmunology: interactions of the bone and immune system

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Autoimmune arthritis: the interface between the immune system and joints

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Denosumab in postmenopausal women with low bone mineral density

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Developmentally regulated availability of RANKL and CD40 ligand reveals distinct mechanisms of fetal and adult cross-talk in the thymus medulla

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Projection of an immunological self shadow within the thymus by the aire protein

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

RANK signals from CD4(+)3(-) inducer cells regulate development of Aire-expressing epithelial cells in the thymic medulla

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Colonic dendritic cells, intestinal inflammation, and T cell-mediated bone destruction are modulated by recombinant osteoprotegerin.

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Selective inhibition of RANK blocks osteoclast maturation and function and prevents bone loss in mice

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

The Src family kinase, Lyn, suppresses osteoclastogenesis in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

TRAF family member-associated NF-κB activator (TANK) is a negative regulator of osteoclastogenesis and bone formation

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Requirement for NF-kappaB in osteoclast and B-cell development

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

I{kappa}B kinase (IKK){beta}, but not IKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

c-Fms and the alphavbeta3 integrin collaborate during osteoclast differentiation

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Fos plays an essential role in the upregulation of RANK expression in osteoclast precursors within the bone microenvironment

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Regulation of osteoclast differentiation and function by the CaMK-CREB pathway.

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Fos/AP-1 proteins in bone and the immune system

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Autoamplification of NFATc1 expression determines its essential role in bone homeostasis

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Calcineurin/NFAT signaling in osteoblasts regulates bone mass

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis.

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

NFAT functions as a working memory of Ca2+ signals in decoding Ca2+ oscillation

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Ca2+-NFATc1 signaling is an essential axis of osteoclast differentiation

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals.

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

PLCgamma2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2.

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Osteoimmunology and the effects of the immune system on bone

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

A new mechanism of bone destruction in rheumatoid arthritis: synovial fibroblasts induce osteoclastogenesis

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Th17: an effector CD4 T cell lineage with regulatory T cell ties

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

The IL-23/IL-17 axis in inflammation

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Targeting IL-17 and TH17 cells in chronic inflammation

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

RANK-L and RANK: T cells, bone loss, and mammalian evolution

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Anti-TNF-alpha therapies: the next generation

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Regulation of cancer cell migration and bone metastasis by RANKL.

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Interleukin 6: from bench to bedside

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

The bone marrow at the crossroads of blood and immunity

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Osteoblastic cells regulate the haematopoietic stem cell niche

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Identification of the haematopoietic stem cell niche and control of the niche size

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Lack of evidence that hematopoietic stem cells depend on N-cadherin-mediated adhesion to osteoblasts for their maintenance.

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Strontium can increase some osteoblasts without increasing hematopoietic stem cells.

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Endothelial and perivascular cells maintain haematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche.

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Mesenchymal and haematopoietic stem cells form a unique bone marrow niche

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Treg cells suppress osteoclast formation: a new link between the immune system and bone

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVT049

21 January 2018

Identifiers

10.1093/JB/MVT049

1 reference

Europe PubMed Central

29 August 2017

1 reference

Europe PubMed Central

29 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38113210&oldid=2116254657"